The Board of Directors of Raaj Medisafe India Ltd approved the unaudited financial results for the quarter ended June 30, 2026, during a meeting held on August 12, 2026. In a significant leadership change, the Board appointed Mr. Vipul Parakh as Chief Financial Officer (CFO), effective August 12, 2026, following the resignation of Ms. Fatema Dadani Patel. Shareholders must note that the Register of Members will close from September 15, 2026, to September 21, 2026, to determine eligibility for the upcoming Annual General Meeting (AGM).

Mr. Parakh is a Chartered Accountant with over 28 years of professional experience across the service and manufacturing sectors. His appointment brings expertise in end-to-end financial operations, including financial reporting, budgeting, compliance, and SAP implementation. He has led financial functions in both non-profit and for-profit organizations, with a focus on strategic financial planning and statutory compliance.

Key Appointments and Resignations

The meeting addressed key leadership changes within the company:

AGM and Shareholder Logistics

The Board fixed Monday, September 21, 2026, at 3.00 PM as the date for the 41st Annual General Meeting, to be held via Video Conferencing or Other Audio-Visual Means (VC/OAVM). The cutoff date for determining eligibility to participate in E-voting is September 14, 2026. M/s. M.Maheshwari & Associates has been appointed as the Scrutinizers for the E-voting process.

Compliance and Reporting

The Board took on record the Limited Review Report of the Statutory Auditor regarding the Q1FY26 results. Additionally, the Board noted the Secretarial Audit Report for the year ended March 31, 2026, issued by M/s. M.Maheshwari & Associates, Practicing Company Secretaries. The Directors’ Report and Corporate Governance Report for FY26 were also approved, with authorization granted to designated persons to sign these documents.

The Board adopted the Reconciliation of Share Capital Audit Report for the quarter ended June 30, 2026. It also took on record several reports submitted to the Bombay Stock Exchange (BSE) in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR). These include:

• Statement of Investors’ complaints (included in the Integrated Corporate Governance Report)
• Shareholding Pattern
• Integrated Corporate Governance Report
• Statement of variation of utilization of funds raised on March 26, 2026, through Preferential Allotment of Equity Shares
• Secretarial Compliance Report for the year ended March 31, 2026

Transactions entered into with related parties during the quarter ended June 30, 2026, were also considered and taken on record by the Board.

Raaj Medisafe India Limited will convene its Board of Directors meeting on August 12, 2026, to approve the company’s unaudited financial results for the quarter ended June 30, 2026. The meeting, scheduled for 3:00 P.M. at the company’s registered office in Ujjain, marks the formal review of Q1FY27 performance alongside key administrative appointments. Investors should note that while the financial figures will be finalized during this session, the immediate news value lies in the confirmation of the quarterly reporting timeline and the strategic hiring of a Chief Financial Officer.

The primary objective of the gathering is to consider and appoint a Chief Financial Officer, a move that signals organizational restructuring or succession planning within the finance function. Alongside this appointment, the Board will review the Limited Review Report issued by the Statutory Auditor for the same period. This dual focus on leadership appointment and financial verification ensures that the reported numbers for the quarter are subject to both internal executive oversight and external statutory validation before public dissemination.

Key Agenda Items

The Board’s agenda extends beyond financial approvals to include critical corporate governance and shareholder engagement activities. A detailed breakdown of the scheduled business is provided below:

Preparations for the 41st Annual General Meeting (AGM) constitute a significant portion of the meeting’s workload. The Board will decide the date and time for the AGM, which is planned to be held through Video Conferencing or Other Audio-Visual Means (OAVM). To facilitate this, the directors will fix the cutoff date for eligibility to participate in E-voting and appoint a scrutinizer for the E-voting process. Additionally, the Board will approve the Notice calling the 41st AGM and authorize personnel to sign and issue it.

Compliance and regulatory reporting remain central to the meeting’s proceedings. The Board will take on record the Secretarial Audit Report for the year ended March 31, 2026, issued by M/s M.Maheshwari & Associates, Practicing Company Secretaries. Furthermore, the directors will approve the Directors’ Report and Corporate Governance Report for the fiscal year ended March 31, 2026. These documents are essential for maintaining transparency with regulators and shareholders regarding the company’s governance standards and operational conduct over the past year.

Regulatory Disclosures and Compliance

In adherence to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board will also take on record several reports submitted to the Bombay Stock Exchange (BSE) for the quarter ended June 30, 2026. These include the Statement of Investors’ Complaints, the Shareholding Pattern, the Integrated Corporate Governance Report, and the Statement of Variation of Utilization of Funds raised on March 26, 2026, through Preferential Allotment of Equity Shares. The Board will also adopt the Reconciliation of Share Capital Audit Report for the quarter and review related party transactions entered into during the period. This comprehensive compliance schedule ensures that Raaj Medisafe India Limited meets all statutory disclosure requirements promptly.